InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,690.39
(
-0.32%
)
Post# of 21472
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Hunchbackgeek

Send PM Follow Ignore
Followers 696
Posts 31840
Boards Moderated 8
Alias Born 03/16/2014

Hunchbackgeek

Re: None

Monday, 05/20/2019 3:51:18 PM

Monday, May 20, 2019 3:51:18 PM

Post# of 21472
ACB reported a 20% jump in quarterly net... revenue on Tuesday.

Aurora Cannabis, Inc. (NYSE: ACB) (Market Cap: $9.134B; Share Price: $8.89) reported a 20% jump in quarterly net revenue on Tuesday, as Canada's legalization of recreational cannabis late last year boosted demand.

The Edmonton, Alberta-based company's net revenue rose to C$65.2 million ($48.44 million) from C$54.2 million ($40.27 million) in the second quarter. ($1 = 1.3459 Canadian dollars). https://www.advfn.com/stock-market/NYSE/ACB/stock-news/79942691/biotech-stock-closing-in-on-human-trials?xref=ff_sidebar_quote


.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up